Navigation Links
Start of Phase IIa Study in Acute Lung Injury Patients Marks Development Milestone
Date:12/19/2011

VIENNA, December 19, 2011 /PRNewswire/ --

APEIRON Biologics AG (Apeiron) announced today that GlaxoSmithKline (GSK), exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.

Apeiron today announced the initiation of a phase IIa clinical study of rhACE2, in patients with Acute Lung Injury (ALI). The study, of which Apeiron's licensee GSK is sponsor, will include subjects with a positive diagnosis of ALI, and will be conducted in the intensive care units of multiple hospitals throughout the United States and Canada.

ALI is an acute, severe injury to the lungs associated with a variety of underlying conditions, such as sepsis, aspiration of acidic gastric contents, trauma, postoperative complications, acute pancreatitis, and pneumonia. According to recent studies, it annually affects hundreds of thousands of individuals worldwide. There are currently no pharmaceutical therapies available to treat this life-threatening condition. The most severe form of ALI, the Acute Respiratory Distress Syndrome (ARDS) has a mortality rate of over 20-40%. The efficacy of GSK2586881 has been tested in several preclinical animal models of ALI/ARDS. A phase I study in healthy volunteers also investigated the safety, tolerability and pharmacology profile of this investigational medicine.  In January 2010, GSK acquired an exclusive, worldwide license to further develop and commercialize GSK2586881 in a deal worth up to EUR 230 Mio, subject to reaching future development milestones in multiple indications.

Hans Loibner, CEO of Apeiron stated: "We are excited to see our innovative biologic APN01, after only 6 years in development, now being tested by our licensee GSK in a multicentric phase II study in ALI patients. The study is designed to provide import
'/>"/>

SOURCE APEIRON Biologics AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Mexican State of Tamaulipas Starts Training Doctors in Sangui Wound Management
2. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
3. Garage Start-ups Now Possible in Life Sciences Industry
4. Angioslide Named One of Israels Top Ten Most Promising Startups of 2011
5. False starts can sneak by in womens sprinting
6. Good Start Genetics™ Announces Validation Results for its Next-Generation DNA Sequencing Platform for Genetic Disorder Carrier Screening
7. ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV
8. Midwest Health Care Startups Raise $315 Million in First Half of 2011
9. Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
10. Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802
11. BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... San Antonio, TX (PRWEB) August 29, 2014 ... 9001:2008 and ISO 13485:2003 certified, GAMP® 5 compliant ... been awarded an international Phase II clinical trial ... non-Hodgkin’s lymphoma. , Throughout this trial, Intrinsic Imaging ... but not limited to, protocol and charter development, ...
(Date:8/28/2014)... 2014 Best Sanitizers, Inc., a leader ... processing industry, is asking industry professionals to prepare for ... the E2 soap they’re currently using to the Best ... Hand hygiene is critical to fighting cross-contamination and ... Six key criteria are identified to evaluate the effectiveness ...
(Date:8/28/2014)... Lawrence, MA (PRWEB) August 28, 2014 “This ... single test to screen from 0 to 150 ppb,” said ... test is a significant benefit to plant owners and USDA-GIPSA ... corn and other commodities. Testing can take place in a ... Not only can the plant test the feed and grain ...
(Date:8/28/2014)... important devices in spintronics, an electronic which is ... but also on their spin and the spin-related ... into magnetic signals and vice versa. Recently, the ... Institute of Physics at Johannes Gutenberg University Mainz ... and Japan, has for the first time realised ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2A new, tunable device for spintronics 2A new, tunable device for spintronics 3
... Neuftec,Limited, the proprietor of the original nano-particulate ... litigation in the,UK against Oxonica Energy Limited, a ... issued in the High Court of Justice, allege ... an injunction against Oxonica as well as damages,in ...
... Senesco,Technologies, Inc. ("Senesco" or the "Company") (Amex: ... presenting at the Business Forum during BIO 2008,the ... held at the San Diego Convention Center from ... Senesco, will deliver the,Company,s corporate presentation on Wednesday, ...
... CHURCH, Va., June 12 CSC (NYSE: ... HealthTrio LLC to add portal and personal,health record ... and other payer clients. The added components include ... October 2007, FirstPortfolio provides users with a,collection of ...
Cached Biology Technology:Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica 2Senesco Technologies to Present at BIO 2008 Business Forum 2CSC and HealthTrio Team to Offer Portal and Personal Health Record Solution 2CSC and HealthTrio Team to Offer Portal and Personal Health Record Solution 3
(Date:8/31/2014)... is developing drugs that are highly effective against a ... patient. Such properties are directly related to the 3D ... have a shape that is perfectly complementary to a ... specificity. Publishing in Nature Chemistry , EPFL scientists ... the 3D structure of bioactive peptides and enhance their ...
(Date:8/31/2014)... Nature Climate Change , suggests that if current ... exceed, the global targets for total greenhouse gas (GHG) emissions ... all think carefully about the food we choose and its ... is just one of a number of actions that need ... there is enough food for all. , As populations ...
(Date:8/29/2014)... have made some surprising discoveries about the body,s ... virus (SIV), the team found that specialized cells ... responders to viral invasion and are the source ... interleukin-1 beta (IL-1β). , Though aimed at ... the gut epithelium that provides a barrier to ...
Breaking Biology News(10 mins):A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3Changing global diets is vital to reducing climate change 2Changing global diets is vital to reducing climate change 3Changing global diets is vital to reducing climate change 4The early cost of HIV 2
... in billions, sometimes - like the snow bunting ... distances and enduring the most extreme frigid weather conditions. ... a stunning success of biological adaptation with Snow ... north as the Arctic Circle. Indeed, there is nothing ...
... be a household name even among farm families, but ... environmentally-friendly commercial biofuel feedstock, particularly for biodiesel and jet ... has just awarded $5.08 million to a team of ... Grain Science and Industry, Xiuzhi "Susan" Sun, to study ...
... coughs, soot or black carbon turns out to ... only to carbon dioxide, according to a four-year assessment by ... the soot particles in smoke and smog, contributes about twice ... the 2007 Intergovernmental Panel on Climate Change. "We were surprised ...
Cached Biology News:Novel approach to track migration of arctic-breeding avian species 2Novel approach to track migration of arctic-breeding avian species 3Researcher awarded $5.08 million to study oilseed camelina as biofuel feedstock 2Researcher awarded $5.08 million to study oilseed camelina as biofuel feedstock 3International study: Where there's smoke or smog, there's climate change 2International study: Where there's smoke or smog, there's climate change 3
... Glycosylation is a post-translational modification ... biological functions, including immune regulation, inflammation, ... Biotechnology has developed two lectin based ... and Wheat Germ Agglutinin (WGA), that ...
... carrier proteins to simplify the production ... Carrier Proteins are commonly used carriers ... heterobifunctional cross-linker (Sulfo-SMCC). This activation results ... Thus allowing the maleimide-activated carrier ...
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
Cell Culture Flask, nontreated polystyrene...
Biology Products: